From the onset of the coronavirus outbreak, healthcare workers and scientists have been working tirelessly to study the virus, test drugs and vaccines, and control the disease’s spread. We have scaled up production dramatically to respond to rapid spread of the disease, moving to 24-hour, seven-day-a-week operations at our manufacturing sites. (Updated March 12)

This World TB Day, it's time to know your TB status – and to test and treat latent TB. Read patient stories, watch expert webinars, and help spread the word about the global fight to End TB.

The SARS-CoV-2 panel is the first syndromic testing solution to get U.S. agency’s development support, expanding QIAGEN’s global mobilization to scale up testing supplies for COVID-19 response.

Internationally recognized molecular testing and measurement research expert Dr. Jim Huggett of the NML will discuss high-accuracy measurements using digital PCR. Join him on March 31.

Finding a rare allele or mutant sequence is a typical needle in a haystack problem. A novel fully integrated nanoplate-based digital PCR technology combines the power of partitioning with the ease of use of qPCR, making absolute quantification of the rare more accessible.